Skip to content

Category: Press

Press
01/22/2025
A Potential New Approach to Treating Addiction

GLP-1 (Glucagon-like peptide-1 receptor agonists), originally developed for type 2 diabetes and obesity, are now being explored for their potential to treat substance use disorders (SUD). Early research suggests these medications could help curb addictive behaviors, opening much needed novel treatment approaches for addiction.  What is GLP-1? GLP-1 is a hormone that helps regulate blood … Continued

Read More
Press
02/21/2024
Innovative Life-Saving Naloxone Delivery System. Exclusive Agreement Secured.

VICTORIA, BC, Feb. 21, 2023 /CNW/ – Sunshine Earth Labs Ltd. (“Sunshine Labs” or “Sunshine”) a Canadian-based biosciences company that aims to provide harm reduction products to the global market, is thrilled to announce its exclusive distribution agreement with PharmaPac, a U.S. national point-of-care medication dispensing solutions provider. Under this exclusive agreement, Waxed International, a subsidiary … Continued

Read More
Press
12/07/2023
Sunshine Earth Labs Ltd. Announces Non-Brokered Private Placement Unit Offering

VICTORIA, BC, Dec. 7, 2023 /CNW/ – Sunshine Earth Labs Ltd. (“Sunshine Labs” or the “Company”), a Canadian-based biosciences company that aims to provide harm reduction products to the global market, today announced that it is launching a non-brokered private placement (the “Offering”) for proceeds of up to C$2,500,000, which Offering is not subject to a minimum raise. The … Continued

Read More
Press
12/07/2023
Sunshine Earth Labs Ltd. and Optimi Health Corp. Announce Strategic Supply Agreement

VICTORIA, BC, Dec. 7, 2023 /CNW/ – Sunshine Earth Labs Ltd. (“Sunshine Labs” or “Sunshine”), a Canadian-based biosciences company that aims to provide harm reduction products to the global market, today announced it has entered into a supply agreement with Optimi Health Corp. (“Optimi”), a leading end-to-end drug researcher and formulator licensed by Health Canada. Under terms of … Continued

Read More
Press
03/03/2023
Sunshine Earth Labs Ltd. Amends Corporate Update

VICTORIA, BC, March 3, 2023 /CNW/ Sunshine Earth Labs Ltd. (“Sunshine Labs” or the “Company”) retracts  the previous corporate update distributed on March 2, 2023 and provides the amended update below. NOTE: Sunshine Labs is licensed by Health Canada to conduct the following regulated activities: possession, production, assembling, sale/provision and sending, transportation and delivery with coca leaf, cocaine, … Continued

Read More
Press
03/02/2023
Sunshine Earth Labs Provides Corporate Update

VICTORIA, BC, March 2, 2023 Cision News Wire‍ Sunshine Earth Labs Ltd. (“Sunshine Labs” or the “Company”) a Canadian-based biosciences company that aims to bring a safer supply of drugs to the global market, has published a corporate update highlighting the progress that has been made since receiving its Health Canada Dealer’s License for Psilocybin … Continued

Read More